Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.10EUR
−10.32 MEUR
7.86 MEUR
20.81 M
About ReShape Lifesciences, Inc.
Sector
Industry
CEO
Paul F. Hickey
Website
Headquarters
San Clemente
Employees (FY)
31
Founded
2002
FIGI
BBG00F0XFJ96
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 24O0 is 0.64 EUR — it has increased by 103.82% in the past 24 hours. Watch RESHAPE LIFESCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange RESHAPE LIFESCIENCES INC stocks are traded under the ticker 24O0.
24O0 reached its all-time high on Feb 3, 2023 with the price of 24.68 EUR, and its all-time low was 0.26 EUR and was reached on Sep 29, 2023. View more price dynamics on 24O0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
24O0 stock is 206.45% volatile and has beta coefficient of 1.53. Track RESHAPE LIFESCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is RESHAPE LIFESCIENCES INC there?
Today RESHAPE LIFESCIENCES INC has the market capitalization of 4.20 M, it has decreased by 12.23% over the last week.
Yes, you can track RESHAPE LIFESCIENCES INC financials in yearly and quarterly reports right on TradingView.
RESHAPE LIFESCIENCES INC is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
RESHAPE LIFESCIENCES INC revenue for the last quarter amounts to 1.80 M EUR, despite the estimated figure of 1.95 M EUR. In the next quarter, revenue is expected to reach 2.06 M EUR.
24O0 net income for the last quarter is −2.03 M EUR, while the quarter before that showed −1.54 M EUR of net income which accounts for −32.11% change. Track more RESHAPE LIFESCIENCES INC financial stats to get the full picture.
No, 24O0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 1, 2024, the company has 31.00 employees. See our rating of the largest employees — is RESHAPE LIFESCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESHAPE LIFESCIENCES INC EBITDA is −10.29 M EUR, and current EBITDA margin is −166.92%. See more stats in RESHAPE LIFESCIENCES INC financial statements.
Like other stocks, 24O0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESHAPE LIFESCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESHAPE LIFESCIENCES INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESHAPE LIFESCIENCES INC stock shows the sell signal. See more of RESHAPE LIFESCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.